Published in Cancer Weekly, April 26th, 2005
In 1997, two randomized trials - the Hormonal Replacement Therapy - Is It Safe' (HABITS) trial and the Stockholm trial - began in Sweden to test the effects of menopausal hormone therapy in women after they had been diagnosed with early-stage breast cancer. The HABITS trial, which ultimately included 434 breast cancer patients, was halted early in December 2003 because at a median follow-up of only 2.1 years the risk of breast cancer recurrence among women receiving hormone therapy was 3.3 times higher than the risk...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.